Discuss formulation needs early
Bring prescriber requirements and patient-specific considerations to a scheduled formula development meeting before setting launch expectations.
MIDLIFE WOMEN’S HEALTH & HORMONE THERAPY
Build the pharmacy side of your women’s health or hormone therapy program with a team that can discuss patient-specific formulation needs, connect fulfillment updates and support your clinic’s brand experience.
Shipping to all 50 states + DC
LET’S BUILD YOUR PHARMACY PLAN
Launching a clinic. Expanding a program. Looking for a better fit. Start a conversation about the fulfillment partnership your team needs.
THE WOMEN’S HEALTH LAUNCH KIT
Give your clinical and operations teams a shared starting point for a midlife care program. Prescribing decisions remain with the treating clinician; formulation requests are subject to pharmacy review.
Bring prescriber requirements and patient-specific considerations to a scheduled formula development meeting before setting launch expectations.
Identify how medication lists, allergies, prescription workflow status and shipping information fit into your existing care platform.
We are licensed in all 50 states and the District of Columbia, so one pharmacy relationship can cover your whole patient base.
WHAT WE PREPARE
Estradiol, estriol and Bi-Est (estradiol and estriol), prepared as hypoallergenic creams, an olive oil base topical or vaginal preparations.
Oral capsules in a cellulose base, or an olive oil base topical, at the strength on the prescription.
A hypoallergenic cream or an olive oil base topical, and a topical gel when a prescriber requests one.
Estradiol and estriol vaginal creams, estriol combined with DHEA, and a hyaluronic acid vaginal base.
Oral capsules, compounded to order for each patient.
For patients beginning therapy, a Bi-Est topical and a progesterone capsule can be prepared together as one order.
Related: Prescribing compounded estradiol · OB-GYN & menopause practices · NP & PA-led practices · White-label fulfillment · Pharmacy integrations · Women's health information for patients
MORE OF YOUR PROGRAM, CONNECTED
Bring your clinical, technical and brand requirements into the same partnership conversation.
Send orders through a direct API connection. Available connections also cover workflow status, medication lists, allergies, production and batch release updates, shipping and tracking.
Meet with our formula development team ahead of launch. Products are researched, developed and tested before staff rollout. NDAs are available for proprietary work.
Choose white-label or branded packaging with a pharmacy-approved, compliant prescription label. Define the details as part of your fulfillment agreement.
BEFORE YOUR FIRST SHIPMENT
Formula development starts in scheduled meetings ahead of launch. Together, we define the work required to move from an idea to a program your staff is prepared to support.
Discuss your patient population, clinical requirements, platform, anticipated volume and launch goals.
Schedule formulation discussions before launch. Arrange an NDA before sharing proprietary details.
Proposed products are researched, developed and tested before staff rollout. Confirm program feasibility and readiness with our team.
Agree on integration scope, packaging, fulfillment contracts and billing terms. Prepare staff and coordinate the rollout.
OPTIONAL: SPECIALTY DETAILS
Choose the program you want to discuss. You can start a conversation here, or read the specialty details first.
Plan a midlife care or hormone therapy program.
Connect formulation planning with your brand experience.
Align clinical requirements with pharmacy operations.
Have another specialty in mind? Tell us what you’re building.
CLEAR EXPECTATIONS
Agree on the scope before you build your launch around it.
Yes. Our formula development team can meet with you before launch, and we can work under an NDA. Proposed products are researched, developed and tested before staff rollout. Feasibility and terms are established during that process.
No. This is pharmacy and operational launch planning for clinics. Clinical assessment, treatment selection and monitoring remain with the treating clinician.
Bioidentical estrogens (estradiol, estriol and Bi-Est), progesterone, testosterone for women, DHEA and pregnenolone, plus vaginal preparations. Each one is prepared for the named patient at the strength the prescriber writes.
Estrogens and testosterone are prepared as topical or vaginal preparations: a hypoallergenic cream, an olive oil base topical or a vaginal cream. Oral capsules are used for progesterone and DHEA. Testosterone is poorly absorbed when it is taken by mouth, so we do not prepare it as a tablet or an oral capsule.
No. We do not compound hormone pellets of any hormone at any strength, hormone patches, injectables of any kind, or troches and lozenges. Knowing that up front saves your prescribers a conversation later.
Yes. Hypoallergenic bases are our default for creams, and dye-free, lactose-free or filler-free options are available when a patient reacts to an ingredient in a commercially manufactured product. A pharmacist reviews every formulation before it is made.
We ship to all 50 states and Washington, DC. Your program’s medication and fulfillment requirements are reviewed during onboarding.
We compound most preparations within 48 hours of receiving a complete, valid prescription and the resolution of any patient, clinical or payment requirements. Custom formulations, controlled medications, high-volume launches and preparations requiring additional testing or release procedures may require additional time. Shipping time is additional.
Yes. Fulfillment contracts and billing terms are provided as part of establishing the partnership. Program-specific scope and responsibilities are discussed before rollout.
Yes. Clinics and partners of any kind are welcome to schedule a site visit to see our operation in Johnson City, Tennessee. Mention it in the form on this page or call 423-975-0597, and we will set a date with you.
Pharmacy services and proposed formulations are subject to clinical and pharmacy review and applicable requirements. Launch planning does not replace a clinician’s assessment or establish that a medication is appropriate for a particular patient.
Compounded preparations are not reviewed or approved by the FDA for safety or efficacy.